158 related articles for article (PubMed ID: 3499859)
1. Effect of PSK on cytotoxicity against sarcoma-180 in tumor-bearing mice.
Oguchi Y; Ando T; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K
Anticancer Res; 1987; 7(4B):681-4. PubMed ID: 3499859
[TBL] [Abstract][Full Text] [Related]
2. Effect of PSK on prohibited immunity of splenectomized mice.
Fujii T; Kano T; Saito K; Kobayashi Y; Iijima H; Matsumoto T; Yoshikumi C; Taguchi T
Anticancer Res; 1987; 7(4B):845-8. PubMed ID: 3674771
[TBL] [Abstract][Full Text] [Related]
3. [Restoration of immunologic responsiveness by PSK in tumor-bearing animals].
Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3468-75. PubMed ID: 3789758
[TBL] [Abstract][Full Text] [Related]
4. [Restoration of depressed immune responses by PSK in C3H/He mice bearing the syngeneic X5563 tumor].
Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3453-60. PubMed ID: 3789756
[TBL] [Abstract][Full Text] [Related]
5. [Depression of protective mechanisms against ectromelia virus infection in tumor-bearing mice and its prevention by PSK].
Taniguchi M; Tsuru S; Kitani H; Zinnaka Y; Nomoto K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2760-5. PubMed ID: 6095765
[TBL] [Abstract][Full Text] [Related]
6. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
[TBL] [Abstract][Full Text] [Related]
8. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
Algarra I; Collado A; Garrido F
J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of PSK, a protein-bound polysaccharide preparation against candidiasis in tumor-bearing mice.
Uetsuka A; Satoh S; Ohno Y
Adv Exp Med Biol; 1979; 121B():21-31. PubMed ID: 546134
[TBL] [Abstract][Full Text] [Related]
10. Competitive action of a biological response modifier, PSK, on a humoral immunosuppressive factor produced in tumor-bearing hosts.
Matsunaga K; Morita I; Iijima H; Endo H; Oguchi Y; Yoshimura M; Fujii T; Yoshikumi C; Nomoto K
J Clin Lab Immunol; 1990 Mar; 31(3):127-36. PubMed ID: 1966997
[TBL] [Abstract][Full Text] [Related]
11. [Augmentation of resistance against metastatic tumor cells after local administration of PSK].
Tsuru S; Taniguchi M; Shinomiya N; Takasaki T; Ageta T; Tanaka T; Kobayashi S; Zinnaka Y; Nomoto K
Gan To Kagaku Ryoho; 1985 Jan; 12(1):86-90. PubMed ID: 3871320
[TBL] [Abstract][Full Text] [Related]
12. Effects of PSK, an antitumor protein-bound polysaccharide, on the surface charge of lymphocytes in X5563-bearing mice.
Hayashi H; Fujii T; Fujii M; Yoshikumi C; Kawai Y; Shimizu M; Iwaguchi T
J Clin Lab Immunol; 1987 Sep; 24(1):33-7. PubMed ID: 3681950
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the antitumor effect by the concurrent use of a monoclonal antibody and the protein-bound polysaccharide PSK in mice bearing a human cancer cell line.
Kanoh T; Saito K; Matsunaga K; Oguchi Y; Taniguchi N; Endoh H; Yoshimura M; Fujii T; Yoshikumi C
In Vivo; 1994; 8(2):241-5. PubMed ID: 7919129
[TBL] [Abstract][Full Text] [Related]
14. [Effect of PSK on tumor-specific immunity induced by MMC-treated syngeneic tumor cells].
Tsuru S; Oguchi M; Mashiko M; Aiso S; Zinnaka Y; Nomoto K
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1634-9. PubMed ID: 6820923
[TBL] [Abstract][Full Text] [Related]
15. Antitumor cells found in tumor-bearing mice given ubenimex.
Ishizuka M; Masuda T; Mizutani S; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1987 May; 40(5):697-701. PubMed ID: 3497141
[TBL] [Abstract][Full Text] [Related]
16. The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice.
Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
Anticancer Res; 1987; 7(3 Pt B):509-12. PubMed ID: 3631910
[TBL] [Abstract][Full Text] [Related]
17. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
Sakai K; Chang AE; Shu SY
Cancer Res; 1990 Jul; 50(14):4371-6. PubMed ID: 2114215
[TBL] [Abstract][Full Text] [Related]
18. [Augmentation of antitumor immune responses by the antitumor antibiotic bleomycin].
Hosokawa M; Morikawa K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2700-8. PubMed ID: 6210061
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors.
Algarra I; Collado A; Garcia Lora A; Garrido F
J Exp Clin Cancer Res; 1999 Mar; 18(1):39-46. PubMed ID: 10374675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
